7Baggers
 Published on: 2025-11-15 04:00:26  newser.com Sat, 15 Nov 2025 10:00:26 GMT
 Caribou Biosciences reveals new data on CAR-T supply chain strategies  Traders Union Fri, 14 Nov 2025 14:15:15 GMT
 Caribou Biosciences earnings beat by $0.05, revenue fell short of estimates  Investing.com Nigeria Fri, 14 Nov 2025 01:26:13 GMT
 published on: 2025-11-13 17:52:46  newser.com Thu, 13 Nov 2025 23:52:46 GMT
 published on: 2025-11-13 14:26:34  newser.com Thu, 13 Nov 2025 20:26:34 GMT
 Caribou Biosciences Reports Increased Losses Amid R&D Focus  TipRanks Thu, 13 Nov 2025 04:29:51 GMT
 Caribou Biosciences earnings beat by $0.05, revenue fell short of estimates  Investing.com India Thu, 13 Nov 2025 02:52:36 GMT
 Caribou Biosciences reports Q3 EPS (30c) vs. (38c) last year  TipRanks Wed, 12 Nov 2025 22:36:53 GMT
 Caribou Biosciences Q3 net loss narrows  MarketScreener Wed, 12 Nov 2025 21:34:38 GMT
 CRISPR PD-1 knockout allogeneic CAR-T matches autologous  CRISPR Medicine News Wed, 12 Nov 2025 12:52:43 GMT
 published on: 2025-11-10 05:07:45  newser.com Mon, 10 Nov 2025 11:07:45 GMT
 The week in pharma: action, reaction and insight – week to November 7  The Pharma Letter Sun, 09 Nov 2025 11:23:58 GMT
 why caribou biosciences inc. stock is considered a top pick  Fundação Cultural do Pará Thu, 06 Nov 2025 00:38:26 GMT
 crbu stock: hc wainwright & co. boosts price target to $9.00 | c  GuruFocus Wed, 05 Nov 2025 12:26:37 GMT
 truist securities reiterates buy rating on caribou biosciences stock by investing.com  Investing.com South Africa Wed, 05 Nov 2025 02:47:28 GMT
 3 penny stocks to watch now, 11/4/25  MSN Tue, 04 Nov 2025 15:45:00 GMT
 published on: 2025-11-04 03:55:22  newser.com Tue, 04 Nov 2025 09:55:22 GMT
 Truist Securities reiterates Buy rating on Caribou Biosciences stock  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 Caribou Bio leaps on early data for vispa-cel  The Pharma Letter Mon, 03 Nov 2025 15:53:32 GMT
 caribou shares surge on positive data from two drug studies  富途牛牛 Mon, 03 Nov 2025 14:17:00 GMT
 Caribou says its off-the-shelf CAR-T hits autologous benchmarks  FirstWord Pharma Mon, 03 Nov 2025 12:54:47 GMT
 Caribou Biosciences to Participate in Upcoming Investor Conferences  Investing News Network Mon, 03 Nov 2025 08:00:00 GMT
 Caribou Biosciences Reports Positive ANTLER Phase 1 Results  TipRanks Mon, 03 Nov 2025 08:00:00 GMT
 Caribou Biosciences price target raised to $8 from $5 at Citi  TipRanks Mon, 03 Nov 2025 08:00:00 GMT
 CRBU: Citigroup Analyst Raises Price Target for Caribou Bioscien  GuruFocus Mon, 03 Nov 2025 08:00:00 GMT

Caribou Biosciences Inc
(NASDAQ:CRBU) 

CRBU stock logo

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Founded: 2011
CEO / Co-Founder: Rachel Haurwitz 
Sector:
Industry:

Share this website to your friends